Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S G Chi

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Oncology Reports|October 19, 1999
Mutational alteration of the p16CDKN2a tumor suppressor gene is infrequent in Ewing's sarcomaY K Park, S G Chi, Y W Kim, et al.
Oncology Research|November 4, 2000
Mutational alterations of the p16CDKN2A tumor suppressor gene have low incidence in mesenchymal chondrosarcomaD K Bae, Y K Park, S G Chi, et al.
The Journal of Pathology|May 1, 2001
Increased expression of cFLIP(L) in colonic adenocarcinomaB K Ryu, M G Lee, S G Chi, et al.
Cancer|December 24, 1997
p53-independent response of a human breast carcinoma xenograft to radioimmunotherapyM D Winthrop, S J DeNardo, J T Muenzer, et al.
Journal of Korean Medical Science|September 19, 1998
Detection of t(11;22)(q24;q12) translocation of Ewing's sarcoma in paraffin embedded tissue by nested reverse transcription-polymerase chain reactionY K Park, S G Chi, H R Park, et al.
Journal of the National Cancer Institute|November 17, 1993
p53 mutations in benign prostatic hyperplasiaF J Meyers, S G Chi, J R Fishman, et al.
International Journal of Oncology|September 20, 2001
Low incidence of genetic alterations of the p16CDKN2a in clear cell chondrosarcomaY K Park, C H Cho, S G Chi, et al.
Cancer Research|June 26, 1999
Elevated and biallelic expression of p73 is associated withprogression of human bladder cancerS G Chi, S G Chang, S J Lee, et al.
Journal of the National Cancer Institute|June 15, 1994
p53 in prostate cancer: frequent expressed transition mutationsS G Chi, R W deVere White, F J Meyers, et al.
Cancer|January 5, 1999
Very frequent p53 mutations in metastatic prostate carcinoma and in matched primary tumorsF J Meyers, P H Gumerlock, S G Chi, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Oncology Reports|October 19, 1999
Mutational alteration of the p16CDKN2a tumor suppressor gene is infrequent in Ewing's sarcomaY K Park, S G Chi, Y W Kim, et al.
Oncology Research|November 4, 2000
Mutational alterations of the p16CDKN2A tumor suppressor gene have low incidence in mesenchymal chondrosarcomaD K Bae, Y K Park, S G Chi, et al.
The Journal of Pathology|May 1, 2001
Increased expression of cFLIP(L) in colonic adenocarcinomaB K Ryu, M G Lee, S G Chi, et al.
Cancer|December 24, 1997
p53-independent response of a human breast carcinoma xenograft to radioimmunotherapyM D Winthrop, S J DeNardo, J T Muenzer, et al.
Journal of Korean Medical Science|September 19, 1998
Detection of t(11;22)(q24;q12) translocation of Ewing's sarcoma in paraffin embedded tissue by nested reverse transcription-polymerase chain reactionY K Park, S G Chi, H R Park, et al.
Journal of the National Cancer Institute|November 17, 1993
p53 mutations in benign prostatic hyperplasiaF J Meyers, S G Chi, J R Fishman, et al.
International Journal of Oncology|September 20, 2001
Low incidence of genetic alterations of the p16CDKN2a in clear cell chondrosarcomaY K Park, C H Cho, S G Chi, et al.
Cancer Research|June 26, 1999
Elevated and biallelic expression of p73 is associated withprogression of human bladder cancerS G Chi, S G Chang, S J Lee, et al.
Journal of the National Cancer Institute|June 15, 1994
p53 in prostate cancer: frequent expressed transition mutationsS G Chi, R W deVere White, F J Meyers, et al.
Cancer|January 5, 1999
Very frequent p53 mutations in metastatic prostate carcinoma and in matched primary tumorsF J Meyers, P H Gumerlock, S G Chi, et al.
Pageof 4